Phlexglobal
Who owns Phlexglobal?
Phlexglobal is a British HealthTech company, now owned by PharmaLex, which acquired it in 2022 from Vitruvian Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey facts
- ·Fully exited in 2022 to PharmaLex.
- ·Average hold across 2 realized cycles: 4 years.
Ownership history
2 ownership periods
Bridgepoint sold Phlexglobal to Vitruvian Partners in 2016 after 2 years.
Vitruvian Partners sold Phlexglobal to PharmaLex in 2022 after 6 years.
More from Vitruvian Investment Partnership II
Other portfolio companies in the same fund.
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
Questions
Who owns Phlexglobal?
Phlexglobal is now owned by PharmaLex, which acquired it in 2022 from Vitruvian Partners.
When did PharmaLex acquire Phlexglobal?
PharmaLex acquired Phlexglobal in 2022, buying from Vitruvian Partners.
Who did Phlexglobal sell to?
Vitruvian Partners sold Phlexglobal to PharmaLex in 2022 (Trade Sale). Bridgepoint sold Phlexglobal to Vitruvian Partners in 2016 (Secondary).
Who has owned Phlexglobal over time?
Phlexglobal has been through 2 private-equity ownership periods: Bridgepoint · via Europe VII (BE VII) · 2014–2016 · sold to Vitruvian Partners · (Secondary); Vitruvian Partners · via Vitruvian Investment Partnership II · 2016–2022 · sold to PharmaLex · (Trade Sale).